Articles

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

Department of Haematology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Josep Carreras Leukemia Research Institutes, Universitat Autònoma de Barcelona, Spain
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic and IDIBAPS, Universitat de Barcelona, Spain;Laboratory of Cytology. Department of Pathology, GRETNHE, IMIM Hospital del Mar Research Institute, Barcelona, Spain
Department of Haematology, Hospital Universitari Arnau de Vilanova, Universitat de Lleida, Spain
Department of Haematology, Hospital Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
Department of Haematology. Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain
Department of Haematology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Josep Carreras Leukemia Research Institutes, Universitat Autònoma de Barcelona, Spain
Department of Haematology, Hospital Universitari Arnau de Vilanova, Universitat de Lleida, Spain
Department of Haematology, Hospital Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
Department of Haematology. Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain
Department of Haematology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Josep Carreras Leukemia Research Institutes, Universitat Autònoma de Barcelona, Spain
Department of Haematology, Hospital Universitari Arnau de Vilanova, Universitat de Lleida, Spain
Department of Haematology, Hospital Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain
Laboratory of Cytology. Department of Pathology, GRETNHE, IMIM Hospital del Mar Research Institute, Barcelona, Spain
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic and IDIBAPS, Universitat de Barcelona, Spain
Department of Haematology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Josep Carreras Leukemia Research Institutes, Universitat Autònoma de Barcelona, Spain
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic and IDIBAPS, Universitat de Barcelona, Spain
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic and IDIBAPS, Universitat de Barcelona, Spain
Vol. 102 No. 6 (2017): June, 2017 https://doi.org/10.3324/haematol.2016.158303